Format

Send to

Choose Destination
Oncotarget. 2016 Apr 26;7(17):23885-96. doi: 10.18632/oncotarget.8127.

Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation.

Author information

1
Department of Molecular Oncology, Moffitt Cancer Center, Tampa, FL, USA.
2
Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, FL, USA.
3
The Genome Institute, Washington University, St. Louis, MO, USA.
4
Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
5
Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.
6
Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
7
Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
8
Department of Medicine, Washington University, St. Louis, MO, USA.
9
Department of Genetics, Washington University, St. Louis, MO, USA.
10
Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL, USA.
11
Department of Medicine, NYU Langone Medical Center, New York, NY, USA.

Abstract

Inactivation of Ras GTPase activating proteins (RasGAPs) can activate Ras, increasing the risk for tumor development. Utilizing a melanoma whole genome sequencing (WGS) data from 13 patients, we identified two novel, clustered somatic missense mutations (Y472H and L481F) in RASA1 (RAS p21 protein activator 1, also called p120RasGAP). We have shown that wild type RASA1, but not identified mutants, suppresses soft agar colony formation and tumor growth of BRAF mutated melanoma cell lines via its RasGAP activity toward R-Ras (related RAS viral (r-ras) oncogene homolog) isoform. Moreover, R-Ras increased and RASA1 suppressed Ral-A activation among Ras downstream effectors. In addition to mutations, loss of RASA1 expression was frequently observed in metastatic melanoma samples on melanoma tissue microarray (TMA) and a low level of RASA1 mRNA expression was associated with decreased overall survival in melanoma patients with BRAF mutations. Thus, these data support that RASA1 is inactivated by mutation or by suppressed expression in melanoma and that RASA1 plays a tumor suppressive role by inhibiting R-Ras, a previously less appreciated member of the Ras small GTPases.

KEYWORDS:

R-Ras; RASA1; RasGAP; melanoma; whole genome sequencing

PMID:
26993606
PMCID:
PMC5029671
DOI:
10.18632/oncotarget.8127
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center